NEW DELHI, India, June 9 — Honeywell (NYSE: HON) announced today a multi-year distribution agreement with Loba Chemie, a global supplier of chemicals, laboratory supplies and equipment, under which Loba Chemie will distribute Honeywell’s high-purity solvents to India’s growing pharmaceutical sector.

Marketed and sold under the Burdick& Jackson(R) brand name, Honeywell’s high-purity solvents are critical to the successful research, development and approval cycle of pharmaceuticals. Terms of the agreement were not disclosed.

“India is an important market for us as the pharmaceutical industry continues to experience tremendous growth,” said Robert Tupker, commercial director for Honeywell’s Specialty Chemicals business in Europe, Middle East, Africa and India. “This agreement will further help position us as a leader in providing a wide range of high-purity solvents for pharmaceutical companies worldwide.”

Vic Shah, director international sales for Loba Chemie, said both companies aim to reach a new standard of success in the high-quality chemicals market in India. “We believe there are a lot of untapped opportunities to be explored, especially in the booming pharmaceutical industry,” said Shah.

The annual growth rate of India’s pharmaceutical market is estimated to be 8 to 9 percent, according to various industry reports.

Major applications for Honeywell’s solvents include analytical instrumental analysis, such as high-performance liquid chromatography (HPLC), as well as pilot and full scale production of pharmaceuticals. Honeywell also offers reagents for DNA and RNA synthesis.

Honeywell manufactures its solvents at the company’s Muskegon, Michigan and Seelze, Germany sites. Loba Chemie, based in Mumbai, has more than 350 distributors throughout India.

For more information, visit www.burdickandjackson.com or www.lobachemie.com.

Honeywell Specialty Materials, based in Morristown, N.J., is a $4.9 billion, global leader in providing customers with high-performance specialty materials, including fluorine products; specialty films and additives; advanced fibers and composites; intermediates; specialty chemicals; electronic materials and chemicals; and technologies and materials for petroleum refining.

Honeywell International is a $37 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit www.honeywell.com.

This report contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management’s assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.